US2019300928A1PendingUtilityA1

Rapid microbial detection

54
Assignee: 3I DIAGNOSTICS INCPriority: May 31, 2013Filed: May 7, 2019Published: Oct 3, 2019
Est. expiryMay 31, 2033(~6.9 yrs left)· nominal 20-yr term from priority
B01L 2300/0681B01L 2200/141B01L 2300/023B01L 2200/0684B01L 3/502753B01L 2200/10C12Q 1/04B01L 2200/0647B01L 2300/044B01L 3/50825C12Q 1/24
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Devices and methods are provided to detect the presence of bacteria and small microorganisms, and to identify various microbial attributes rapidly.

Claims

exact text as granted — not AI-modified
1 . A method of processing within a microfluidic device a sample that includes microorganisms and non-microbial cells, the method comprising:
 selectively lysing material including non-microbial cells to form lysed debris within the sample while leaving intact microorganisms within the sample.   
     
     
         2 . The method of  claim 1 , further comprising:
 separating and removing lysed debris from non-lysed and intact microorganisms within the sample.   
     
     
         3 . The method of  claim 1 , further comprising:
 identifying the intact microorganisms within the sample.   
     
     
         4 . The method of  claim 2 , further comprising:
 identifying the intact microorganisms within the sample.   
     
     
         5 . The method of  claim 2 , further comprising collecting lysed debris separated from the sample in a waste collection stage of the microfluidic device. 
     
     
         6 . The method of  claim 2 , wherein the separating and removing lysed debris from non-lysed and intact microorganisms within the sample occurs without using a nucleotide, an antibody, or other ligand or reagent that specifically recognizes and binds to a microorganism. 
     
     
         7 . The method of  claim 1 , wherein the microorganisms are selected from the group consisting of bacteria, fungi, and small unicellular and multicellular organisms. 
     
     
         8 . The method of  claim 1 , wherein the microorganisms are selected from the group of genera consisting of  Staphylococcus, Escherichia, Listeria, Salmonella, Streptococcus, Klebsiella  and  Campylobacter.    
     
     
         9 . The method of  claim 1 , wherein the sample is a liquid selected from the group consisting of whole blood, plasma, serum, saliva, urine, cerebrospinal fluid, water, and fruit and vegetable juices. 
     
     
         10 . The method of  claim 1 , wherein the sample is selected from the group consisting of meat, produce, processed food, dairy products, poultry products, pharmaceutical process streams, bulk drug substance, and final drug product. 
     
     
         11 . The method of  claim 1 , wherein the sample has a volume ranging from about 0.1 mL to about 10 mL. 
     
     
         12 . The method of  claim 3 , wherein the identifying intact microorganisms within the sample comprises:
 subjecting the sample to infrared spectrometric analysis utilizing a detector; and   determining a presence of intact microorganisms within the sample based upon the infrared spectrometric analysis.   
     
     
         13 . The method of  claim 12 , wherein the identifying intact microorganisms within the sample further comprises:
 determining a species of one or more intact microorganisms within the sample based upon the infrared spectrometric analysis.   
     
     
         14 . The method of  claim 12 , wherein the determining a species of one or more intact microorganisms within the sample further comprises:
 providing data associated with the infrared spectrometric analysis to a computer device for determination of the species of the one or more intact microorganisms.   
     
     
         15 . The method of  claim 12 , wherein the determining a species of one or more intact microorganisms within the sample further comprises:
 comparing spectral data obtained from the infrared spectrometric analysis with spectral data from a database; and   identifying the species of the microorganism based upon the comparing.   
     
     
         16 . The method of  claim 3 , further comprising:
 prior to identifying the intact microorganisms within the sample, concentrating the microorganisms in the sample via reducing a volume of the sample and/or filtration of the sample.   
     
     
         17 . The method of  claim 1 , wherein the selective lysing is achieved by passing the sample through stationary microporous surfaces. 
     
     
         18 . The method of  claim 17 , wherein the microporous surfaces include pores having diameters from 1 micrometer to 10 micrometers. 
     
     
         19 . The method of  claim 1 , wherein the selective lysing is achieved by passing the sample through a porous monolithic structure including microporous surfaces. 
     
     
         20 . The method of  claim 1 , further comprising, prior to the selective lysing, separating and removing from the sample components that are larger in size than microorganisms within the sample. 
     
     
         21 . The method of  claim 20 , wherein the separation and removal from the sample components that are larger in size than microorganisms within the sample comprises passing the sample through a channel having a spiral path within the microfluidic device. 
     
     
         22 . The method of  claim 20 , wherein the separation of lysed debris from non-lysed and intact microorganisms within the sample comprises passing the sample through a linear array of posts within the microfluidic device to separate, via deterministic lateral displacement (DLD), lysed debris from the sample while maintaining the microbial cells of interest within the sample.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.